Show Parent

May

ERJ Podcast Eur Respir J 2015; 45: E53
Barriers to new drug development in respiratory disease Barnes Peter J., Bonini Sergio, Seeger Werner, Belvisi Maria G., Ward Brian, Holmes Anthony Eur Respir J 2015; 45: 1197-1207
Combination therapy in idiopathic pulmonary fibrosis: the way ahead will be hard Wells Athol Eur Respir J 2015; 45: 1208-1210
What is new about Rio? Souza Rogerio, Kawut Steven M. Eur Respir J 2015; 45: 1211-1213
Lung cancer in never-smokers Planchard David, Besse Benjamin Eur Respir J 2015; 45: 1214-1217
Where do we go from here? Clinical drug development in idiopathic pulmonary fibrosis Collard Harold R. Eur Respir J 2015; 45: 1218-1220
Development of a syllabus for postgraduate respiratory physiotherapy education: the Respiratory Physiotherapy HERMES project Troosters Thierry, Pitta Fabio, Oberwaldner Beatrice, Lewko Agnieszka, Inal-Ince Deniz, Grant Kathleen, Gosselink Rik, Burtin Chris, Emtner Margareta, Clini Enrico, Chatwin Michelle, Mitchell Sharon Eur Respir J 2015; 45: 1221-1223
A free lung health check for the European Parliament: Healthy Lungs for Life Faure Marine Eur Respir J 2015; 45: 1224-1225
From the Museum: the Art of Thinking. Summary 5-8: Sensing In Kotsimbos Tom Eur Respir J 2015; 45: 1226-1227
Indoor air quality, ventilation and respiratory health in elderly residents living in nursing homes in Europe Bentayeb Malek, Norback Dan, Bednarek Micha, Bernard Alfred, Cai Guihong, Cerrai Sonia, Eleftheriou Konstantinos Kostas, Gratziou Christina, Holst Gitte Juel, Lavaud François, Nasilowski Jacek, Sestini Piersante, Sarno Giuseppe, Sigsgaard Torben, Wieslander Gunilla, Zielinski Jan, Viegi Giovanni, Annesi-Maesano Isabella Eur Respir J 2015; 45: 1228-1238
Global and regional trends in COPD mortality, 1990–2010 Burney Peter G.J., Patel Jaymini, Newson Roger, Minelli Cosetta, Naghavi Mohsen Eur Respir J 2015; 45: 1239-1247
Obesity as a susceptibility factor to indoor particulate matter health effects in COPD McCormack Meredith C., Belli Andrew J., Kaji Deepak A., Matsui Elizabeth C., Brigham Emily P., Peng Roger D., Sellers Cortlandt, Williams D'Ann L., Diette Gregory B., Breysse Patrick N., Hansel Nadia N. Eur Respir J 2015; 45: 1248-1257
Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition Gohy Sophie T., Hupin Cloé, Fregimilicka Chantal, Detry Bruno R., Bouzin Caroline, Gaide Chevronay Héloïse, Lecocq Marylène, Weynand Birgit, Ladjemi Maha Z., Pierreux Christophe E., Birembaut Philippe, Polette Myriam, Pilette Charles Eur Respir J 2015; 45: 1258-1272
Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma Vogelmeier Claus, Kardos Peter, Hofmann Thomas, Canisius Sebastian, Scheuch Gerhard, Muellinger Bernhard, Nocker Karlheinz, Menz Guenter, Rabe Klaus F. Eur Respir J 2015; 45: 1273-1282
Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test Hankinson John L., Eschenbacher Bill, Townsend Mary, Stocks Janet, Quanjer Philip H. Eur Respir J 2015; 45: 1283-1292
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2) Simonneau Gérald, D’Armini Andrea M., Ghofrani Hossein-Ardeschir, Grimminger Friedrich, Hoeper Marius M., Jansa Pavel, Kim Nick H., Wang Chen, Wilkins Martin R., Fritsch Arno, Davie Neil, Colorado Pablo, Mayer Eckhard Eur Respir J 2015; 45: 1293-1302
Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2) Rubin Lewis J., Galiè Nazzareno, Grimminger Friedrich, Grünig Ekkehard, Humbert Marc, Jing Zhi-Cheng, Keogh Anne, Langleben David, Fritsch Arno, Menezes Flavia, Davie Neil, Ghofrani Hossein-Ardeschir Eur Respir J 2015; 45: 1303-1313
PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension Galiè Nazzareno, Müller Katharina, Scalise Andrea-Viviana, Grünig Ekkehard Eur Respir J 2015; 45: 1314-1322
Age-adjusted high-sensitivity troponin T cut-off value for risk stratification of pulmonary embolism Kaeberich Anja, Seeber Valerie, Jiménez David, Kostrubiec Maciej, Dellas Claudia, Hasenfuß Gerd, Giannitsis Evangelos, Pruszczyk Piotr, Konstantinides Stavros, Lankeit Mareike Eur Respir J 2015; 45: 1323-1331
Obstructive respiratory events and premature atrial contractions after cardioversion Linz Dominik, Hohl Mathias, Ukena Christian, Mahfoud Felix, Wirth Klaus, Neuberger Hans-Ruprecht, Böhm Michael Eur Respir J 2015; 45: 1332-1340
Complicated grief after death of a relative in the intensive care unit Kentish-Barnes Nancy, Chaize Marine, Seegers Valérie, Legriel Stéphane, Cariou Alain, Jaber Samir, Lefrant Jean-Yves, Floccard Bernard, Renault Anne, Vinatier Isabelle, Mathonnet Armelle, Reuter Danielle, Guisset Olivier, Cohen-Solal Zoé, Cracco Christophe, Seguin Amélie, Durand-Gasselin Jacques, Éon Béatrice, Thirion Marina, Rigaud Jean-Philippe, Philippon-Jouve Bénédicte, Argaud Laurent, Chouquer Renaud, Adda Mélanie, Dedrie Céline, Georges Hugues, Lebas Eddy, Rolin Nathalie, Bollaert Pierre-Edouard, Lecuyer Lucien, Viquesnel Gérard, Léone Marc, Chalumeau-Lemoine Ludivine, Garrouste Maïté, Schlemmer Benoit, Chevret Sylvie, Falissard Bruno, Azoulay Élie Eur Respir J 2015; 45: 1341-1352
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis Torres Antoni, Cillóniz Catia, Ferrer Miquel, Gabarrús Albert, Polverino Eva, Villegas Santiago, Marco Francesc, Mensa Josep, Menéndez Rosario, Niederman Michael Eur Respir J 2015; 45: 1353-1363
Incidence of occupational latent tuberculosis infection in South African healthcare workers Adams Shahieda, Ehrlich Rodney, Baatjies Roslynn, van Zyl-Smit Richard N., Said-Hartley Qonita, Dawson Rodney, Dheda Keertan Eur Respir J 2015; 45: 1364-1373
Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis Ley Brett, Bradford Williamson Z., Weycker Derek, Vittinghoff Eric, du Bois Roland M., Collard Harold R. Eur Respir J 2015; 45: 1374-1381
Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis Ogura Takashi, Taniguchi Hiroyuki, Azuma Arata, Inoue Yoshikazu, Kondoh Yasuhiro, Hasegawa Yoshinori, Bando Masashi, Abe Shinji, Mochizuki Yoshiro, Chida Kingo, Klüglich Matthias, Fujimoto Tsuyoshi, Okazaki Kotaro, Tadayasu Yusuke, Sakamoto Wataru, Sugiyama Yukihiko Eur Respir J 2015; 45: 1382-1392
Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis Wilkes David S., Chew Terrence, Flaherty Kevin R., Frye Sarah, Gibson Kevin F., Kaminski Naftali, Klemsz Michael J., Lange Wade, Noth Imre, Rothhaar Katia Eur Respir J 2015; 45: 1393-1402
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers Couraud Sébastien, Souquet Pierre-Jean, Paris Christophe, Dô Pascal, Doubre Hélène, Pichon Eric, Dixmier Adrien, Monnet Isabelle, Etienne-Mastroianni Bénédicte, Vincent Michel, Trédaniel Jean, Perrichon Marielle, Foucher Pascal, Coudert Bruno, Moro-Sibilot Denis, Dansin Eric, Labonne Stéphanie, Missy Pascale, Morin Franck, Blanché Hélène, Zalcman Gérard Eur Respir J 2015; 45: 1403-1414
No impact of passive smoke on the somatic profile of lung cancers in never-smokers Couraud Sébastien, Debieuvre Didier, Moreau Lionel, Dumont Patrick, Margery Jacques, Quoix Elisabeth, Duvert Bernard, Cellerin Laurent, Baize Nathalie, Taviot Bruno, Coudurier Marie, Cadranel Jacques, Missy Pascale, Morin Franck, Mornex Jean-François, Zalcman Gérard, Souquet Pierre-Jean Eur Respir J 2015; 45: 1415-1425
The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis Grimminger Friedrich, Günther Andreas, Vancheri Carlo Eur Respir J 2015; 45: 1426-1433
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis Wollin Lutz, Wex Eva, Pautsch Alexander, Schnapp Gisela, Hostettler Katrin E., Stowasser Susanne, Kolb Martin Eur Respir J 2015; 45: 1434-1445
Management of bronchiectasis in adults Chalmers James D., Aliberti Stefano, Blasi Francesco Eur Respir J 2015; 45: 1446-1462
Influenza virus-induced lung injury: pathogenesis and implications for treatment Herold Susanne, Becker Christin, Ridge Karen M., Budinger G.R. Scott Eur Respir J 2015; 45: 1463-1478
The global epidemiology of chronic cough in adults: a systematic review and meta-analysis Song Woo-Jung, Chang Yoon-Seok, Faruqi Shoaib, Kim Ju-Young, Kang Min-Gyu, Kim Sujeong, Jo Eun-Jung, Kim Min-Hye, Plevkova Jana, Park Heung-Woo, Cho Sang-Heon, Morice Alyn H. Eur Respir J 2015; 45: 1479-1481
Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients Pouwels Simon D., Nawijn Martijn C., Bathoorn Erik, Riezebos-Brilman Annelies, van Oosterhout Antoon J.M., Kerstjens Huib A.M., Heijink Irene H. Eur Respir J 2015; 45: 1482-1485
Increased expression of granzymes A and B in fatal asthma Annoni Raquel, Silva Luiz Fernando F., Nussbaumer-Ochsner Yvonne, van Schadewijk Annemarie, Mauad Thais, Hiemstra Pieter S., Rabe Klaus F. Eur Respir J 2015; 45: 1485-1488
Defining the appropriate waiting time between multiple-breath nitrogen washout measurements Salamon Elizabeth R., Gain Kevin R., Hall Graham L. Eur Respir J 2015; 45: 1489-1491
Dual gas techniques for peripheral airway function: diffusing the issues Verbanck Sylvia, Paiva Manuel Eur Respir J 2015; 45: 1491-1494
Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension Laveneziana Pierantonio, Humbert Marc, Godinas Laurent, Joureau Barbara, Malrin Roxane, Straus Christian, Jaïs Xavier, Sitbon Olivier, Simonneau Gérald, Similowski Thomas, Garcia Gilles Eur Respir J 2015; 45: 1495-1498
Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid Wells Charles D., Gupta Rajesh, Hittel Norbert, Geiter Lawrence J. Eur Respir J 2015; 45: 1498-1501
Is 1-year follow-up adequate for adult tuberculosis contacts? Feng Jia-Yih, Chen San-Chi, Lee Ming-Che, Fan Wen-Chien, Su Wei-Juin, Hu Yu-Wen, Yeh Chiu-Mei, Chen Tzeng-Ji, Liu Chia-Jen Eur Respir J 2015; 45: 1501-1504
Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients Metcalfe John Z., Makumbirofa Salome, Makamure Beauty, Mutetwa Reggie, Peñaloza Renée A., Sandy Charles, Bara Wilbert, Mungofa Stanley, Hopewell Philip C., Mason Peter Eur Respir J 2015; 45: 1504-1506
Cough hypersensitivity syndrome: clinical measurement is the key to progress Turner Richard D., Bothamley Graham H. Eur Respir J 2015; 45: 1507-1508
Cough hypersensitivity syndrome: clinical measurement is the key to progress Morice Alyn H., Millqvist Eva, Belvisi Maria G., Bieksiene Kristina, Birring Surinder S., Chung Kian Fan, Dal Negro Roberto W., Dicpinigaitis Peter, Kantar Ahmad, McGarvey Lorcan P., Pacheco Adalberto, Sakalauskas Raimundas, Smith Jaclyn A. Eur Respir J 2015; 45: 1509-1510
Screening for latent tuberculosis before tumour necrosis factor antagonist therapy Hewitt Richard J., Singanayagam Aran, Sridhar Saranya, Wickremasinghe Melissa, Min Kon Onn Eur Respir J 2015; 45: 1510-1512
Screening for latent tuberculosis before tumour necrosis factor antagonist therapy Loebinger Michael R., Pozniak Anton Eur Respir J 2015; 45: 1512-1513
Are C-reactive protein levels associated with bacteria in COPD exacerbations? Miravitlles Marc, Llor Carl Eur Respir J 2015; 45: 1514-1515
Are C-reactive protein levels associated with bacteria in COPD exacerbations? Clark Tristan W. Eur Respir J 2015; 45: 1515-1516
Erratum Eur Respir J 2015; 45: 1517